Global Clinical In Vitro Diagnostic Medical Laboratory Services Markets 2021-2025 - Alternative Medicine Creates Testing Opportunity & Genetic Based Testing Creates New Department and New Discipline
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market, Q4 2021" report has been added to ResearchAndMarkets.com's offering.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
The Clinical Laboratory has seen steady growth for the last 20 years, but this is changing with the effect of the COVID pandemic on healthcare and economic activity. Worse still, Point of Care and Self Testing are threatening long term demand. Understand the opportunities and the threats in this comprehensive report.
The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.
Exciting technical developments, especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2021 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.
Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
Cooperative Aims to Expand Clinical, Commercial NGS Access
Emerging COVID-19 Sequencing Assays - An Alternative to Existing Diagnostics?
CDC Ranks Two More Microbes as 'Urgent Threat'
ACLA Requests $5 billion to keep private labs going
Applied Biology to Launch New Laboratory for Hair and Skin Disorders
Quest Diagnostics Acquires Outreach Operations
Quest Diagnostics Buys Assets of Boston Clinical Laboratory Services
CLA Urges FDA to Halt Crackdown on PGx Testing
Quest Diagnostics Subsidiary Buys True Health Dx Assets
BioReference Laboratories selected by IPA Association
Predictive Laboratories Announces Research Collaboration
NEOMED-LABS / Pacific Biomarkers Acquires PAIRimmune Francais
LabCorp and Envigo Complete Transactions
PathGroup Acquires Pathologists Bio-Medical Laboratories
Predictive Technology Acquires Taueret Laboratories
Quest Diagnostics Acquires Laboratory Services Business of Boyce & Bynum Pathology
Laboratories
Gestalt Diagnostics Expands Market Reach with Peak Medical Acquisition
Amazon exploring consumer health diagnostics
Quest Diagnostics Acquires Laboratory Services Operation in Central Michigan
NeoGenomics to acquire Genoptix, Inc
Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
Charles River Labs to acquire contract research firm for $800M
GROUPE BIO7 to be Sold to CERBA HEALTHCARE
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
Trends Driving a Changing Market
Growth Is Pushed from Many Sides
Understanding the Impact of Aging Population.
COVID Related Testing Growth
Point of Care Testing can increase demand
Alternative Medicine Creates Testing Opportunity
Esoteric Testing Moving Mainstream
Genetic Based Testing Creates New Department and New Discipline
Factors at Work to Shrink The Market
COVID 19 Recession
Economic or population contraction.
Testing usage analysis curtailing growth
Wellness has a downside
Test Displacement Impacts Important
Point of Care Testing
Automation
Stranded LIMS Investment
Software as a Service
Physician Office and Access Systems
Environment and Evolution
Diagnostic Technology Development
Next Generation Sequencing Fuels a Revolution
Impact of NGS on pricing
POCT/Self Testing Disruptive Force
Pharmacogenomics Blurs Diagnosis and Treatment
CGES Testing, A Brave New World
Molecular Diagnostics Technologies at The Forefront of Growth
Biochips/Giant magneto resistance based assay
Profiles of Key Companies
Acibadem Labmed Laboratory
ACM Medical Laboratory
Adicon Clinical Laboratories
American Bio-Clinical Laboratories, Int'l
American Pathology Partners
ARUP Laboratories
Ascend Clinical
Aurora Diagnostics
Bio-Reference Laboratories
Bioscientia Institut fur Medizinische Diagnostik GmbH
BP Healthcare Group
Clinical Reference Laboratory
Clongen Laboratories
CompuNet Clinical Laboratories
Diagnosticos da America
DIAN Diagnostics Co., Ltd
Enzo Life Sciences, Inc
Eurofins Scientific
Exagen Diagnostics
Genomic Health
Genzyme Corporation
Gribbles Pathology
Guangzhou Kingmed Diagnostics Group Co., Ltd
Integrated Regional Laboratories
KDL Group
Laboratory Corporation of America
Lifelabs
Mayo Clinic Laboratories
Mid America Clinical Laboratories
Myriad Genetics/Myriad RBM
NeoGenomics
Pathology, Inc.
Psychemedics Corporation
Quest Diagnostics
RDL Reference Laboratory
Sonic Healthcare
Spectra Laboratories
Synlab Group
Unilabs
For more information about this report visit https://www.researchandmarkets.com/r/ii5fo9
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900